8-Hour MAT Waiver Training
This CME activity is a dynamic, web-based, computer-guided experience that allows learners to participate in the training “on their own time” to receive CME Credit and a Buprenorphine Training Certificate.
Release Date: January 23, 2015 Expiration Date: January 23, 2018
American Academy of Addiction Psychiatry is accredited by the ACCME to provide continuing medical education for physicians.
American Academy of Addiction Psychiatry designates this enduring material for a maximum of 8 AMA PRA Category 1 Credits™. Providers should claim only the credit commensurate with the extent of their participation in the activity.
Method of provider participation in the learning process
A few minutes after you purchase the course, you should see the email in your Inbox. If you do not, please check your email program's Junk or Spam folder.
The estimated time to complete all modules in this activity is 8 hours. To receive 8 AMA PRA Category 1 Credits™ and a Buprenorphine Training Completion Certificate you must:
Once you sign up and submit your payment for this training, you must complete the course within 45 days of registering. No refunds will be issued.
This program is designed for providers who are likely to treat patients with opioid use disorders in their practice, such as those in family practice, general internal medicine, psychiatry, pediatrics, and adolescent medicine specialists. This online training is especially valuable for:
At the conclusion of this course, participants should be able to:
The system requirements for participation include:
Copyright ©2014 American Academy of Addiction Psychiatry - All Rights Reserved
The cost to purchase the course is
$124 AAAP Members
Want to become an AAAP member? Learn more about Member benefits and ways you can save!
REVIEW MODULE OBJECTIVES
Introduction and Accreditation
Module 1: Introduction to Treating SUDs
Module 2: Review of Opioids and Treatment
Module 3: History and Pharmacology: Opioid Dependence Treatment with Buprenorphine
Module 4: Utilizing and Prescribing Buprenorphine/Naxolone: Research, Safety and Drug Interactions
Module 5: Patient Evaluation Module 6: The Clinical Use of Buprenorphine.
Module 7: Office Management and the Treatment Environment
Module 8: Special Treatment Populations and the Use of Buprenorphine
Cvent Online Event Registration Software | Copyright © 2000-2017 Cvent, Inc. All rights reserved.